Biofilms and Why They Resist Antibiotics and Disinfectants
Bacteria do not always live as single cells. Many of them build biofilms, which are sticky communities attached to a surface. As a result, these communities survive treatments that kill free-floating bacteria. That difference matters in hospitals, water systems, and medical devices.
A biofilm starts when a few cells attach to a surface. The surface can be a catheter, a wound dressing, a tooth, or a pipe. Then the cells multiply and release a matrix of sugars, proteins, and DNA. This matrix holds the community together. It also limits how fast drugs and disinfectants reach the cells inside.
Antibiotics face three problems in a biofilm. First, the matrix slows entry, so the dose at the center stays low. Second, many cells inside grow slowly or enter a dormant state. Most antibiotics work best on actively dividing cells. Therefore, slow growers survive even when the drug reaches them. Third, bacteria in biofilms trade resistance genes more easily because they sit close together. Over time, the community can hold several defense traits at once.
Disinfectants meet a similar barrier. A surface may look clean after a wipe, yet cells under the matrix remain. In addition, the outer layer can react with chlorine, alcohol, or other agents before those agents reach deeper cells. Repeated low exposure can also select tougher strains. That is why contact time and mechanical cleaning matter as much as the chemical itself.
Biofilms also change the local environment. Inner zones can run low on oxygen and nutrients. Waste products can lower the pH. These shifts reduce drug activity even further. Meanwhile, outer cells die and release signals that help the survivors adjust. The community therefore acts less like a crowd of identical cells and more like a layered structure.
In medicine, this pattern shows up on implants, catheters, and chronic wounds. Standard lab tests often use free-floating bacteria, so they can overestimate how well a drug will work on a device-related infection. Clinicians may need longer treatment, device removal, or a combined approach. Researchers are testing enzymes that break the matrix, coatings that block attachment, and phage mixes that target biofilm cells.
Prevention still beats treatment. Sterile insertion, fewer device-days, and thorough cleaning reduce the chance that a film will form. Once a mature biofilm sets, antibiotics and disinfectants alone often fail to clear it.
Disclaimer: This article explains general microbiology for information only. It is not medical advice and does not recommend any treatment. Infection control and antibiotic choices should follow a qualified clinician and current lab guidance.